SAN LUIS OBISPO, California – April 28, 2011 – FzioMed, Inc. announced today the launch of www.fziomed.com that has been transformed into an interactive tool to enhance the online experience of Healthcare Professionals, Distributors and Consumers searching for healthcare information.
The primary objective when designing the website was to provide an effective medium that would showcase the growing amount of data that supports the use of Oxiplex technology to reduce pain and the extent and severity of adhesions that occur as a consequence of surgery.
John Krelle, President and Chief Executive Officer said, “Now that our products are commercially available in 70 countries worldwide, it makes sense to put all of the studies and scientific support in one place so that these references may be accessed in support of our technology. New countries now seeing our products for the first time such as Brazil, Mexico and Canada now have the ability to fully appreciate the clinical performance of all our brands.”
FzioMed is a privately held medical device company developing and commercializing absorbable, surgical biomaterials based on the company’s patented science. FzioMed’s polymer technology has uses in a variety of surgical specialties including orthopedics, spine, gynecology and general surgery.
FzioMed® and Oxiplex® are registered trademarks of FzioMed, Inc.